Qinge Shan1, Jianxiang Shi2, Xiaohui Wang3, Jun Guo1, Xiao Han1, Zhehai Wang4, Haiyong Wang5. 1. Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China. 2. Henan Academy of Medical and Pharmaceutical Sciences, Precision Medicine Center, Zhengzhou University, Zhenzhou, Henan, China. 3. Research Service Office, Shandong Liaocheng People's Hospital, Liaocheng, Shandong, China. 4. Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China. badgood007@126.com. 5. Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China. wanghaiyong6688@126.com.
Abstract
BACKGROUND: The prognosis of patients with small cell lung cancer (SCLC) is poor, most of them are in the extensive stage at the time of diagnosis, and are prone to brain metastasis. In this study, we established a nomogram combined with some clinical parameters to predict the survival of SCLC patients with brain metastasis. METHODS: The 3522 eligible patients selected from the SEER database between 2010 and 2015 were randomly divided into training cohort and validation cohort. Univariate and multivariate Cox regression analysis were used to evaluate the ability of each parameter to predict OS. The regression coefficients obtained in multivariate analysis were visualized in the form of nomogram, thus a new nomogram and risk classification system were established. The calibration curves were used to verify the model. And ROC curves were used to evaluate the discrimination ability of the newly constructed nomogram. Survival curves were made by Kaplan-Meier method and compared by Log rank test. RESULTS: Univariate and multivariate analysis showed that age, race, sex, T stage, N stage and marital status were independent prognostic factors and were included in the predictive model. The calibration curves showed that the predicted value of the 1- and 3-year survival rate by the nomogram was in good agreement with the actual observed value of the 1- and 3-year survival rate. And, the ROC curves implied the good discrimination ability of the predictive model. In addition, the results showed that in the total cohort, training cohort, and validation cohort, the prognosis of the low-risk group was better than that of the high-risk group. CONCLUSIONS: We established a nomogram and a corresponding risk classification system to predict OS in SCLC patients with brain metastasis. This model could help clinicians make clinical decisions and stratify treatment for patients.
BACKGROUND: The prognosis of patients with small cell lung cancer (SCLC) is poor, most of them are in the extensive stage at the time of diagnosis, and are prone to brain metastasis. In this study, we established a nomogram combined with some clinical parameters to predict the survival of SCLCpatients with brain metastasis. METHODS: The 3522 eligible patients selected from the SEER database between 2010 and 2015 were randomly divided into training cohort and validation cohort. Univariate and multivariate Cox regression analysis were used to evaluate the ability of each parameter to predict OS. The regression coefficients obtained in multivariate analysis were visualized in the form of nomogram, thus a new nomogram and risk classification system were established. The calibration curves were used to verify the model. And ROC curves were used to evaluate the discrimination ability of the newly constructed nomogram. Survival curves were made by Kaplan-Meier method and compared by Log rank test. RESULTS: Univariate and multivariate analysis showed that age, race, sex, T stage, N stage and marital status were independent prognostic factors and were included in the predictive model. The calibration curves showed that the predicted value of the 1- and 3-year survival rate by the nomogram was in good agreement with the actual observed value of the 1- and 3-year survival rate. And, the ROC curves implied the good discrimination ability of the predictive model. In addition, the results showed that in the total cohort, training cohort, and validation cohort, the prognosis of the low-risk group was better than that of the high-risk group. CONCLUSIONS: We established a nomogram and a corresponding risk classification system to predict OS in SCLCpatients with brain metastasis. This model could help clinicians make clinical decisions and stratify treatment for patients.
Entities:
Keywords:
Brain metastasis; Nomogram; Prediction; Small cell lung cancer; Survival
Authors: Björn Hellman; David Brodin; Maria Andersson; Karin Dahlman-Wright; Ulf Isacsson; Daniel Brattstrom; Michael Bergqvist Journal: Exp Oncol Date: 2005-06
Authors: Kim Margolin; Marc S Ernstoff; Omid Hamid; Donald Lawrence; David McDermott; Igor Puzanov; Jedd D Wolchok; Joseph I Clark; Mario Sznol; Theodore F Logan; Jon Richards; Tracy Michener; Agnes Balogh; Kevin N Heller; F Stephen Hodi Journal: Lancet Oncol Date: 2012-03-27 Impact factor: 41.316
Authors: Nathan R Foster; Yingwei Qi; Qian Shi; James E Krook; John W Kugler; James R Jett; Julian R Molina; Steven E Schild; Alex A Adjei; Sumithra J Mandrekar Journal: Cancer Date: 2010-10-19 Impact factor: 6.860
Authors: Ramaswamy Govindan; Nathan Page; Daniel Morgensztern; William Read; Ryan Tierney; Anna Vlahiotis; Edward L Spitznagel; Jay Piccirillo Journal: J Clin Oncol Date: 2006-10-01 Impact factor: 44.544
Authors: Dirk Zaak; Maximilian Burger; Wolfgang Otto; Patrick J Bastian; Stefan Denzinger; Christian G Stief; Hannes Buchner; Arndt Hartmann; Wolf F Wieland; Shahrokh F Shariat; Hans-Martin Fritsche Journal: BJU Int Date: 2009-12-11 Impact factor: 5.588
Authors: Sarah B Goldberg; Scott N Gettinger; Amit Mahajan; Anne C Chiang; Roy S Herbst; Mario Sznol; Apostolos John Tsiouris; Justine Cohen; Alexander Vortmeyer; Lucia Jilaveanu; James Yu; Upendra Hegde; Stephanie Speaker; Matthew Madura; Amanda Ralabate; Angel Rivera; Elin Rowen; Heather Gerrish; Xiaopan Yao; Veronica Chiang; Harriet M Kluger Journal: Lancet Oncol Date: 2016-06-03 Impact factor: 41.316
Authors: Pierre I Karakiewicz; Alberto Briganti; Felix K-H Chun; Quoc-Dien Trinh; Paul Perrotte; Vincenzo Ficarra; Luca Cindolo; Alexandre De la Taille; Jacques Tostain; Peter F A Mulders; Laurent Salomon; Richard Zigeuner; Tommaso Prayer-Galetti; Denis Chautard; Antoine Valeri; Eric Lechevallier; Jean-Luc Descotes; Herve Lang; Arnaud Mejean; Jean-Jacques Patard Journal: J Clin Oncol Date: 2007-04-10 Impact factor: 44.544